ReplayBG is an open-source, digital twin-based framework developed by the University of Padova to retrospectively assess new type 1 diabetes therapies. By creating personalized models from patient data, it allows researchers to simulate glucose responses to alternative insulin and carbohydrate treatments, providing a reliable in-silico tool for evaluating therapy efficacy before clinical implementation.
ReplayBG is an open-source, digital twin-based methodology designed to facilitate the development and assessment of new therapies for type 1 diabetes (T1D) management. By leveraging retrospective data—such as insulin, carbohydrate intake, and continuous glucose monitoring (CGM) readings—ReplayBG creates a personalized model of a patient's glucose-insulin dynamics. This digital twin allows researchers to simulate how a patient's glucose levels would have responded to alternative treatment strategies, providing a robust in-silico framework for evaluating therapy efficacy before moving to clinical trials.
The framework operates through a two-step process:
The technology is at TRL 6. It has been validated through scientific research, including comparisons with state-of-the-art methodologies and testing on virtual subjects using the UVa/Padova T1D Simulator. It is available as open-source software for research integration and has been documented in peer-reviewed publications, such as IEEE Transactions on Biomedical Engineering.
Founded in 1222, the University of Padova is a comprehensive public research university with broad disciplinary depth and a strong international profile. Industry engages through co-located labs and shared core facilities offering testing and contract services, plus internship and thesis pathways that place students in company settings. The university is integrated with a major hospital system for clinical research and translation and collaborates with regional technology parks and the Veneto network of industrial districts. Research is supported by competitive European and national programs, including Horizon Europe and the European Research Council. A dedicated technology transfer office streamlines sponsored research, IP, licensing, and startup support for corporate partners.